News

Longevity.Technology
longevity.technology > news > nautilus-expands-single-molecule-proteomics-into-parkinsons

Nautilus expands single-molecule proteomics into Parkinson’s

7+ hour, 2+ min ago  (885+ words) Parkinson's disease is usually diagnosed when symptoms become hard to ignore. By then, the brain has already been changing for years. The biology of those early changes " quiet, gradual and invisible to most tools " remains one of the biggest gaps…...

Longevity.Technology
longevity.technology > news > new-gene-map-sheds-light-on-muscle-loss-in-aging

New gene map sheds light on muscle loss in aging

5+ day, 5+ hour ago  (735+ words) Muscle rarely gets the same attention as the brain or the heart in longevity science. Yet it quietly determines how long we remain independent. When muscle mass and strength decline, a condition known as sarcopenia, the consequences ripple outward. Slower…...

Longevity.Technology
longevity.technology > news > quantum-proteins-engineered-for-magnetic-sensing

Quantum proteins engineered for magnetic sensing

3+ week, 5+ day ago  (578+ words) For researchers used to fluorescent proteins as passive labels, it is an unfamiliar proposition: a reporter that is not just bright or dim, but physically addressable. The route to the MFPs is also a reminder of where modern bioengineering is…...

Longevity.Technology
longevity.technology > news > proxima-lands-80m-to-make-protein-interactions-programmable

Proxima lands $80m to make protein interactions programmable

1+ mon, 2+ day ago  (551+ words) AI-native biotech Proxima has raised $80 million in an oversubscribed seed round to advance new medicines designed to control how proteins interact with one another. Previously known as VantAI, the company has rebranded as Proxima to reflect its focus on "proximity…...

Longevity.Technology
longevity.technology > news > bioage-reports-fast-inflammation-drop-with-bge-102

BioAge reports fast inflammation drop with BGE-102

1+ mon, 3+ day ago  (902+ words) Inflammation builds slowly, often invisibly, shaping the long arc of aging by increasing the risk of heart disease, metabolic dysfunction and neurodegeneration. For years, researchers have known this. What has been missing is a practical way to dial inflammation down…...

Longevity.Technology
longevity.technology > news > nrg-doses-first-volunteers-in-mitochondrial-als-trial

NRG doses first volunteers in mitochondrial ALS trial

1+ mon, 1+ week ago  (869+ words) There are clinical trial announcements that feel routine, and then there are those that quietly redraw the map of where medicine is heading. UK-based clinical-stage neuroscience company NRG Therapeutics has completed its first-in-human dosing of NRG5051, which belongs firmly in the…...

Longevity.Technology
longevity.technology > news > new-mitochondrial-uncouplers-aim-to-raise-energy-burn-safely

New mitochondrial ‘uncouplers’ aim to raise energy burn safely

1+ mon, 1+ week ago  (632+ words) Their central claim is less "we've found a better uncoupler" than "we've learned how to engineer one" " and that distinction matters, because in mitochondria, the difference between a therapeutic nudge and a physiological emergency can be measured in degrees. Mitochondria…...